HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia Sabattini Selected Research

Silvia Sabattini Research Topics

Disease

15Neoplasms (Cancer)
12/2023 - 01/2014
8Neoplasm Metastasis (Metastasis)
06/2023 - 12/2018
4Osteosarcoma (Osteogenic Sarcoma)
03/2023 - 12/2020
3Hemangiosarcoma (Angiosarcoma)
08/2023 - 12/2019
3Lymphoma (Lymphomas)
09/2021 - 01/2019
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 10/2010
2Histiocytic Sarcoma
12/2021 - 12/2020
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2019
2Stomatitis
12/2020 - 01/2020
1Brain Neoplasms (Brain Tumor)
12/2023
1Transitional Cell Carcinoma
07/2023
1Inflammation (Inflammations)
01/2021
1Pain (Aches)
01/2021
1Pathologic Complete Response
01/2021
1Carcinogenesis
12/2020
1Hepatocellular Carcinoma (Hepatoma)
05/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Squamous Cell Carcinoma of Head and Neck
01/2019
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Infections
01/2016
1Carcinoma (Carcinomatosis)
05/2015
1Stomach Neoplasms (Stomach Cancer)
01/2014
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2014

Drug/Important Bio-Agent (IBA)

3thiamine triphosphorate (TTP)IBA
08/2023 - 01/2019
3VaccinesIBA
08/2023 - 01/2019
2Peptides (Polypeptides)IBA
08/2023 - 03/2022
2Connexin 43 (Connexin43)IBA
08/2023 - 03/2022
21- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA
06/2023 - 12/2018
2Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
01/2014 - 10/2010
1MicroRNAs (MicroRNA)IBA
12/2023
1TensinsIBA
12/2023
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2023
1Cyclooxygenase InhibitorsIBA
07/2023
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2023
1Coloring Agents (Dyes)IBA
01/2022
1CannabinoidsIBA
01/2021
1EndocannabinoidsIBA
01/2021
1Platelet-Derived Growth FactorIBA
12/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2020
1Sorafenib (BAY 43-9006)FDA Link
05/2020
1AnthracyclinesIBA
12/2019
1SmokeIBA
01/2019
1ChromatinIBA
01/2019
1Tumor Suppressor Protein p53IBA
01/2019
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2016
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2015
1firocoxibIBA
05/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2014
1Codon (Codons)IBA
01/2014

Therapy/Procedure

6Drug Therapy (Chemotherapy)
08/2023 - 01/2019
4Surgical Amputation (Amputations)
03/2022 - 01/2021
3Adjuvant Chemotherapy
03/2023 - 10/2021
3Lymph Node Excision (Lymph Node Dissection)
01/2022 - 09/2021
3Therapeutics
01/2021 - 01/2014
3Radiotherapy
12/2020 - 05/2015
2Splenectomy
03/2023 - 12/2019
2Immunotherapy
01/2021 - 01/2019
1Cutaneous Administration
03/2022
1Anesthesia
01/2021
1CHOP protocol (VDCP protocol)
01/2019